Study of ventilation during cardiac arrest in cadavers
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests different ways to give breaths during cardiac arrest. It is done on human cadavers to see which method works best, which could help improve emergency care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be over 18 years old.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a specific breathing technique (PEEP) during CPR helps improve outcomes for adults who have a cardiac arrest outside the hospital and are being treated by emergency medical teams.
This trial tests different methods of giving breaths (ventilation) to adults who have a cardiac arrest while in the hospital. It aims to find which approach works best to improve survival.
This trial is testing a special way of giving breaths (ventilation) during CPR to see if it helps more people survive a cardiac arrest outside the hospital. It is for adults whose heart stopped due to a heart problem and were treated by paramedics.
This study looks at lung-related problems that can happen when someone is on a breathing machine after surviving a cardiac arrest. If you qualify, researchers will track your recovery to better understand how to prevent these complications.
This trial tests if giving real-time feedback to rescuers during CPR can improve how they deliver breaths (rate and volume) to a person whose heart has stopped. It may help make ventilation more consistent and effective.
This trial tests a new way to control the breaths given during CPR for adults who have a cardiac arrest in the hospital. The goal is to improve how ventilation is delivered during resuscitation.
Hear when a new Ventilation During Resuscitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.